Amalgamated Bank’s Recursion Pharmaceuticals RXRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $44K | Hold |
8,616
| – | – | ﹤0.01% | 1853 |
|
2025
Q1 | $46K | Buy |
8,616
+1,464
| +20% | +$7.82K | ﹤0.01% | 1813 |
|
2024
Q4 | $48K | Hold |
7,152
| – | – | ﹤0.01% | 1842 |
|
2024
Q3 | $47K | Hold |
7,152
| – | – | ﹤0.01% | 1869 |
|
2024
Q2 | $54K | Buy |
7,152
+2,459
| +52% | +$18.6K | ﹤0.01% | 1840 |
|
2024
Q1 | $47K | Sell |
4,693
-7,251
| -61% | -$72.6K | ﹤0.01% | 1882 |
|
2023
Q4 | $118K | Sell |
11,944
-1,397
| -10% | -$13.8K | ﹤0.01% | 1949 |
|
2023
Q3 | $102K | Hold |
13,341
| – | – | ﹤0.01% | 1990 |
|
2023
Q2 | $100K | Sell |
13,341
-1,188
| -8% | -$8.91K | ﹤0.01% | 2063 |
|
2023
Q1 | $97K | Sell |
14,529
-3,294
| -18% | -$22K | ﹤0.01% | 2069 |
|
2022
Q4 | $137K | Hold |
17,823
| – | – | ﹤0.01% | 2004 |
|
2022
Q3 | $190K | Buy |
17,823
+306
| +2% | +$3.26K | ﹤0.01% | 1876 |
|
2022
Q2 | $143K | Buy |
17,517
+330
| +2% | +$2.69K | ﹤0.01% | 2025 |
|
2022
Q1 | $123K | Sell |
17,187
-1,347
| -7% | -$9.64K | ﹤0.01% | 2124 |
|
2021
Q4 | $317K | Buy |
+18,534
| New | +$317K | ﹤0.01% | 1793 |
|